Agreement between PiCCO pulse-contour analysis, pulmonal artery thermodilution and transthoracic thermodilution

P S Halvorsen1, A Espinoza, R Lundblad

  • 1The Interventional Centre, Department of Anesthesiology at Rikshospitalet-Radiumhospitalet University Hospital, Osly, Norway.

Insights

Continuous cardiac index monitoring is crucial during off-pump coronary artery bypass surgery (OPCAB). Thermodilution methods show better agreement than pulse-contour analysis (PCCI) with thermodilution, suggesting PCCI recalibration is needed.

Area of Science:

  • Cardiovascular Surgery
  • Anesthesiology
  • Critical Care Medicine

Background:

  • Hemodynamic instability can rapidly occur during off-pump coronary artery bypass surgery (OPCAB).
  • Continuous monitoring of cardiac index (CI) is advisable during OPCAB procedures.
  • The PiCCO monitor offers continuous CI measurement via pulse-contour analysis and intermittent measurement via transthoracic thermodilution.

Purpose of the Study:

  • To evaluate the agreement between pulmonary artery thermodilution CI (Tpa), transthoracic thermodilution CI (Tpc), and pulse-contour CI (PCCI) during OPCAB surgery.
  • To determine the reliability of different CI monitoring methods in the context of OPCAB.

Main Methods:

  • 30 patients undergoing OPCAB surgery were enrolled.
  • Pulmonary artery and PiCCO catheters were inserted for simultaneous CI measurements.
  • Tpa, Tpc, and PCCI were compared at multiple time points, including post-induction, post-pericardiothomy, after grafting, and post-chest closure.
  • PCCI was recalibrated between T2 and T6.

Main Results:

  • Limits of agreement (percentage error) between Tpa and Tpc were 22.0%.
  • Limits of agreement between Tpa and PCCI were 33.5%.
  • Limits of agreement between Tpc and PCCI were 35.5%.
  • Analysis of changes in CI (DeltaCI) showed varying limits of agreement between the methods.

Conclusions:

  • Thermodilution methods (Tpa and Tpc) demonstrated smaller limits of agreement compared to PCCI during OPCAB surgery.
  • Pulse-contour analysis (PCCI) showed wider variability when compared to thermodilution methods.
  • Recalibration of the PCCI is recommended to improve its accuracy during OPCAB procedures.
Abstract

Related Concept Videos

Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
352
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
401
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
944
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
232
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
616
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors01:28

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
586